Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 472360, 10 pages
http://dx.doi.org/10.1155/2015/472360
Review Article

Biomarkers of Lung Injury in Cardiothoracic Surgery

1HaemoScan BV, 9723 JC Groningen, Netherlands
2Department of Cardiothoracic Surgery, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, Netherlands

Received 1 January 2015; Accepted 2 March 2015

Academic Editor: Andreas Pich

Copyright © 2015 Gerwin Erik Engels and Willem van Oeveren. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Kolff, D. B. Effler, L. K. Groves, C. R. Hughes, and L. J. McCormack, “Pulmonary complications of open-heart operations: their pathogenesis and avoidance,” Cleveland Clinic Journal of Medicine, vol. 25, no. 2, pp. 65–83, 1958. View at Publisher · View at Google Scholar
  2. C. S. H. Ng, S. Wan, A. P. C. Yim, and A. A. Arifi, “Pulmonary dysfunction after cardiac surgery,” Chest, vol. 121, no. 4, pp. 1269–1277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. P. Taggart, M. El-Fiky, R. Carter, A. Bowman, and D. J. Wheatley, “Respiratory dysfunction after uncomplicated cardiopulmonary bypass,” The Annals of Thoracic Surgery, vol. 56, no. 5, pp. 1123–1128, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. J. T. Christenson, J.-M. Aeberhard, P. Badel et al., “Adult respiratory distress syndrome after cardiac surgery,” Cardiovascular Surgery, vol. 4, no. 1, pp. 15–21, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. F. S. Vargas, A. Cukier, M. Terra-Filho, W. Hueb, L. R. Teixeira, and R. W. Light, “Relationship between pleural changes after myocardial revascularization and pulmonary mechanics,” Chest, vol. 102, no. 5, pp. 1333–1336, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Bonacchi, E. Prifti, G. Giunti, A. Salica, G. Frati, and G. Sani, “Respiratory dysfunction after coronary artery bypass grafting employing bilateral internal mammary arteries: the influence of intact pleura,” European Journal of Cardio-Thoracic Surgery, vol. 19, no. 6, pp. 827–833, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Efthimiou, J. Butler, C. Woodham, M. K. Benson, and S. Westaby, “Diaphragm paralysis following cardiac surgery: role of phrenic nerve cold injury,” Annals of Thoracic Surgery, vol. 52, no. 4, pp. 1005–1008, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. C. I. Coleman, D. M. Lucek, J. Hammond, and C. M. White, “Preoperative statins and infectious complications following cardiac surgery,” Current Medical Research and Opinion, vol. 23, no. 8, pp. 1783–1790, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. M. Ranieri, G. D. Rubenfeld, B. T. Thompson et al., “Acute respiratory distress syndrome: the Berlin definition,” Journal of the American Medical Association, vol. 307, no. 23, pp. 2526–2533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. R. Bernard, A. Artigas, K. L. Brigham et al., “Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination,” Intensive Care Medicine, vol. 20, no. 3, pp. 225–232, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Wynne and M. Botti, “Postoperative pulmonary dysfunction in adults after cardiac surgery with cardiopulmonary bypass: clinical significance and implications for practice,” The American Journal of Critical Care, vol. 13, no. 5, pp. 384–393, 2004. View at Google Scholar · View at Scopus
  12. Biomarkers Definitions Working Group, “Biomarkers and surrogate endpoints: preferred definitions and conceptual framework,” Clinical Pharmacology and Therapeutics, vol. 69, no. 3, pp. 89–95, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Rifai, M. A. Gillette, and S. A. Carr, “Protein biomarker discovery and validation: the long and uncertain path to clinical utility,” Nature Biotechnology, vol. 24, no. 8, pp. 971–983, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Matthay and G. A. Zimmerman, “Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 4, pp. 319–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. M. Kuebler and A. E. Goetz, “The marginated pool,” European Surgical Research, vol. 34, no. 1-2, pp. 92–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Weiss, “Tissue destruction by neutrophils,” The New England Journal of Medicine, vol. 320, no. 6, pp. 365–376, 1989. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Kawabata, T. Hagio, and S. Matsuoka, “The role of neutrophil elastase in acute lung injury,” European Journal of Pharmacology, vol. 451, no. 1, pp. 1–10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Garden, F. Xiao, C. Moak, B. H. Willis, S. Robinson-Jackson, and S. Alexander, “Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 275, no. 2, part 2, pp. H385–H392, 1998. View at Google Scholar · View at Scopus
  19. H. H. Ginzberg, V. Cherapanov, Q. Dong et al., “Neutrophil-mediated epithelial injury during transmigration: role of elastase,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 281, no. 3, pp. G705–G717, 2001. View at Google Scholar · View at Scopus
  20. M. E. Faymonville, J. Pincemail, J. Duchateau et al., “Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans,” The Journal of Thoracic and Cardiovascular Surgery, vol. 102, no. 2, pp. 309–317, 1991. View at Google Scholar · View at Scopus
  21. L. H. Edmunds Jr., “Inflammatory response to cardiopulmonary bypass,” The Annals of Thoracic Surgery, vol. 66, no. 5, supplement 1, pp. S12–S16, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Tonz, T. Mihaljevic, L. K. Von Segesser, J. Fehr, E. R. Schmid, and M. I. Turina, “Acute lung injury during cardiopulmonary bypass are the neutrophils responsible?” Chest, vol. 108, no. 6, pp. 1551–1556, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Hashimoto, H. Miyamoto, K. Suzuki et al., “Evidence of organ damage after cardiopulmonary bypass: the role of elastase and vasoactive mediators,” The Journal of Thoracic and Cardiovascular Surgery, vol. 104, no. 3, pp. 666–673, 1992. View at Google Scholar · View at Scopus
  24. T. Mihaljevic, M. Tönz, L. K. Von Segesser et al., “The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: a clinical study,” The Journal of Thoracic and Cardiovascular Surgery, vol. 109, no. 6, pp. 1138–1145, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. J. Gu, A. J. de Vries, P. Vos, P. W. Boonstra, and W. van Oeveren, “Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit,” The Annals of Thoracic Surgery, vol. 67, no. 3, pp. 604–609, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Kadoi, H. Hinohara, F. Kunimoto et al., “Pilot study of the effects of ONO-5046 in patients with acute respiratory distress syndrome,” Anesthesia & Analgesia, vol. 99, no. 3, pp. 872–877, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. J. J. Driessen, H. Dhaese, G. Fransen et al., “Pulsatile compared with nonpulsatile perfusion using a centrifugal pump for cardiopulmonary bypass during coronary artery bypass grafting: effects on systemic haemodynamics, oxygenation, and inflammatory response parameters,” Perfusion, vol. 10, no. 1, pp. 3–12, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. de Vries, W. J. Vermeijden, Y. J. Gu, J. A. M. Hagenaars, and W. Van Oeveren, “Clinical efficacy and biocompatibility of three different leukocyte and fat removal filters during cardiac surgery,” Artificial Organs, vol. 30, no. 6, pp. 452–457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. J. Klebanoff, “Myeloperoxidase: friend and foe,” Journal of Leukocyte Biology, vol. 77, no. 5, pp. 598–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. E. D. Verrier and E. M. Boyle Jr., “Endothelial cell injury in cardiovascular surgery,” The Annals of Thoracic Surgery, vol. 62, no. 3, pp. 915–922, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. B. E. Miller and J. H. Levy, “The inflammatory response to cardiopulmonary bypass,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 11, no. 3, pp. 355–366, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. P. P. Bradley, D. A. Priebat, R. D. Christensen, and G. Rothstein, “Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker,” Journal of Investigative Dermatology, vol. 78, no. 3, pp. 206–209, 1982. View at Publisher · View at Google Scholar · View at Scopus
  33. D. G. Sinclair, P. L. Haslam, G. J. Quinlan, J. R. Pepper, and T. W. Evans, “The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability,” Chest, vol. 108, no. 3, pp. 718–724, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. G. E. Engels, Y. J. Gu, W. van Oeveren, G. Rakhorst, M. A. Mariani, and M. E. Erasmus, “The utility of lung epithelium specific biomarkers in cardiac surgery: a comparison of biomarker profiles in on- and off-pump coronary bypass surgery,” Journal of Cardiothoracic Surgery, vol. 8, no. 1, article 4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Quaniers, J. Leruth, A. Albert, R. R. Limet, and J.-O. Defraigne, “Comparison of inflammatory responses after off-pump and on-pump coronary surgery using surface modifying additives circuit,” The Annals of Thoracic Surgery, vol. 81, no. 5, pp. 1683–1690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Baldus, V. Rudolph, M. Roiss et al., “Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase,” Circulation, vol. 113, no. 15, pp. 1871–1878, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. T. Buckley and C. Ehrhardt, “The receptor for advanced glycation end products (RAGE) and the lung,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 917108, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Shirasawa, N. Fujiwara, S. Hirabayashi et al., “Receptor for advanced glycation end-products is a marker of type I lung alveolar cells,” Genes to Cells, vol. 9, no. 2, pp. 165–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Mahajan and V. Dhawan, “Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases,” International Journal of Cardiology, vol. 168, no. 3, pp. 1788–1794, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Uchida, M. Shirasawa, L. B. Ware et al., “Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury,” The American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 9, pp. 1008–1015, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Agostoni, C. Banfi, M. Brioschi et al., “Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study,” The European Respiratory Journal, vol. 37, no. 4, pp. 841–847, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. P. R. Tuinman, A. D. Cornet, M. T. Kuipers et al., “Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery,” BMC Pulmonary Medicine, vol. 13, article 76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Liu, Q. Chen, S. Shi et al., “Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children,” Critical Care, vol. 16, no. 3, article R91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Uchida, N. Ohno, M. Asahara et al., “Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgery,” PLoS ONE, vol. 8, no. 7, Article ID e70200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. B. C. Creagh-Brown, G. J. Quinlan, L. R. Hector, T. W. Evans, and A. Burke-Gaffney, “Association between preoperative plasma sRAGE levels and recovery from cardiac surgery,” Mediators of Inflammation, vol. 2013, Article ID 496031, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. C. S. Calfee, M. M. Budev, M. A. Matthay et al., “Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 26, no. 7, pp. 675–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. D. Christie, C. V. Shah, S. M. Kawut et al., “Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction,” The American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 10, pp. 1010–1015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. R. J. Shah, S. L. Bellamy, J. C. Lee et al., “Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome,” The American Journal of Transplantation, vol. 13, no. 3, pp. 754–759, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Singh and S. L. Katyal, “Clara Cells and Clara Cell 10 kD Protein (CC10),” The American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 2, pp. 141–143, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. J. S. Lakind, S. T. Holgate, D. R. Ownby et al., “A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects,” Biomarkers, vol. 12, no. 5, pp. 445–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Broeckaert and A. Bernard, “Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker,” Clinical and Experimental Allergy, vol. 30, no. 4, pp. 469–475, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Hermans and A. Bernard, “Lung epithelium-specific proteins: characteristics and potential applications as markers,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 2, pp. 646–678, 1999. View at Google Scholar · View at Scopus
  53. R. M. Determann, J. L. Millo, S. Waddy, R. Lutter, C. S. Garrard, and M. J. Schultz, “Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study,” BMC Pulmonary Medicine, vol. 9, article 49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. A. Kropski, R. D. Fremont, C. S. Calfee, and L. B. Ware, “Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury,” Chest, vol. 135, no. 6, pp. 1440–1447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Wutzler, T. Lehnert, H. Laurer et al., “Circulating levels of clara cell protein 16 but not surfactant protein D identify and quantify lung damage in patients with multiple injuries,” The Journal of Trauma—Injury, Infection and Critical Care, vol. 71, no. 2, pp. E31–E36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. D. A. Lomas, E. K. Silverman, L. D. Edwards, B. E. Miller, H. O. Coxson, and R. Tal-Singer, “Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort,” Thorax, vol. 63, no. 12, pp. 1058–1063, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Pilette, V. Godding, R. Kiss et al., “Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease,” The American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 1, pp. 185–194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. J. M. Diamond, S. M. Kawut, D. J. Lederer et al., “Elevated plasma Clara cell secretory protein concentration is associated with high-grade primary graft dysfunction,” The American Journal of Transplantation, vol. 11, no. 3, pp. 561–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Greven, E. Krop, N. Burger, H. Kerstjens, and D. Heederik, “Serum pneumoproteins in firefighters,” Biomarkers, vol. 16, no. 4, pp. 364–371, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Nord, K. Schubert, T. N. Cassel, O. Andersson, and G. C. Riise, “Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients,” Transplantation, vol. 73, no. 8, pp. 1264–1269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. R. J. Shah, N. Wickersham, D. J. Lederer et al., “Preoperative plasma club (Clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation,” American Journal of Transplantation, vol. 14, no. 2, pp. 446–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. W.-J. van Boven, W. B. Gerritsen, F. G. Waanders, F. J. Haas, and L. P. Aarts, “Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: a comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function,” Perfusion, vol. 19, no. 4, pp. 239–246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. W. J. P. van Boven, W. B. M. Gerritsen, P. Zanen et al., “Pneumoproteins as a lung-specific biomarker of alveolar permeability in conventional on-pump coronary artery bypass graft surgery vs mini-extracorporeal circuit: a pilot Study,” Chest, vol. 127, no. 4, pp. 1190–1195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. W.-J. P. van Boven, W. B. Gerritsen, A. H. Driessen, E. P. van Dongen, R. J. Klautz, and L. P. Aarts, “Minimised closed circuit coronary artery bypass grafting in the elderly is associated with lower levels of rgan-specific biomarkers: a prospective randomised study,” European Journal of Anaesthesiology, vol. 30, no. 11, pp. 685–694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. G. E. Engels, M. Dodonov, G. Rakhorst et al., “The effect of pulsatile cardiopulmonary bypass on lung function in elderly patients,” The International Journal of Artificial Organs, vol. 37, no. 9, pp. 679–687, 2014. View at Publisher · View at Google Scholar
  66. R. J. King, “Pulmonary surfactant,” Journal of Applied Physiology: Respiratory Environmental & Exercise Physiology, vol. 53, no. 1, pp. 1–8, 1982. View at Google Scholar · View at Scopus
  67. J. A. Whitsett and T. E. Weaver, “Hydrophobic surfactant proteins in lung function and disease,” The New England Journal of Medicine, vol. 347, no. 26, pp. 2141–2148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. U. Kishore, T. J. Greenhough, P. Waters et al., “Surfactant proteins SP-A and SP-D: structure, function and receptors,” Molecular Immunology, vol. 43, no. 9, pp. 1293–1315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. T. E. Weaver and J. A. Whitsett, “Function and regulation of expression of pulmonary surfactant-associated proteins,” The Biochemical Journal, vol. 273, no. 2, pp. 249–264, 1991. View at Google Scholar · View at Scopus
  70. H. P. Haagsman and R. V. Diemel, “Surfactant-associated proteins: Functions and structural variation,” Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol. 129, no. 1, pp. 91–108, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Sano and Y. Kuroki, “The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity,” Molecular Immunology, vol. 42, no. 3, pp. 279–287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. J. R. Wright, “Immunoregulatory functions of surfactant proteins,” Nature Reviews Immunology, vol. 5, no. 1, pp. 58–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Magrì, M. Brioschi, C. Banfi et al., “Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure,” Circulation Heart Failure, vol. 2, no. 3, pp. 175–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. M. W. Sims, M. F. Beers, V. N. Ahya et al., “Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis,” Chest, vol. 140, no. 2, pp. 489–496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. R. M. Determann, E. K. Wolthuis, G. Choi et al., “Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 294, no. 2, pp. L344–L350, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. R. J. Shah, S. L. Bellamy, A. R. Localio et al., “A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation,” The Journal of Heart and Lung Transplantation, vol. 31, no. 9, pp. 942–949, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Shigemura, Y. Nasuhara, S. Konno et al., “Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis,” Journal of Translational Medicine, vol. 10, no. 1, article 111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Kohno, M. Akiyama, S. Kyoizumi, M. Hakoda, K. Kobuke, and M. Yamakido, “Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma,” Japanese Journal of Clinical Oncology, vol. 18, no. 3, pp. 203–216, 1988. View at Google Scholar · View at Scopus
  79. Y. Hirasawa, N. Kohno, A. Yokoyama, Y. Inoue, M. Abe, and K. Hiwada, “KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts,” The American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 4, pp. 501–507, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Kunitake, K. Kuwano, K. Yoshida et al., “KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis,” Respiration, vol. 68, no. 5, pp. 488–495, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Janssen, H. Sato, J. C. Grutters et al., “Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis,” Chest, vol. 124, no. 6, pp. 2119–2125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. J. N. Walter, L. L. Fan, R. Bag et al., “Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation,” Transplantation, vol. 82, no. 5, pp. 709–711, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Ohshimo, F. Bonella, U. Sommerwerck et al., “Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation,” The Journal of Heart and Lung Transplantation, vol. 30, no. 12, pp. 1374–1380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Hussell and T. J. Bell, “Alveolar macrophages: plasticity in a tissue-specific context,” Nature Reviews Immunology, vol. 14, no. 2, pp. 81–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. C. D. Mills, “M1 and M2 macrophages: oracles of health and disease,” Critical Reviews in Immunology, vol. 32, no. 6, pp. 463–488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. J. S. Duffield, “The inflammatory macrophage: a story of Jekyll and Hyde,” Clinical Science, vol. 104, no. 1, pp. 27–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Gordon, “Alternative activation of macrophages,” Nature Reviews Immunology, vol. 3, no. 1, pp. 23–35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. D. F. Gibbs, T. P. Shanley, R. L. Warner, H. S. Murphy, J. Varani, and K. J. Johnson, “Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury: evidence for alveolar macrophage as source of proteinases,” The American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 6, pp. 1145–1154, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Alber, S. E. M. Howie, W. A. H. Wallace, and N. Hirani, “The role of macrophages in healing the wounded lung,” International Journal of Experimental Pathology, vol. 93, no. 4, pp. 243–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Gordon and F. O. Martinez, “Alternative activation of macrophages: mechanism and functions,” Immunity, vol. 32, no. 5, pp. 593–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. W. A. Den Hengst, J. F. Gielis, J. Y. Lin, P. E. Van Schil, L. J. De Windt, and A. L. Moens, “Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 5, pp. H1283–H1299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Zhao, L. G. Fernandez, A. Doctor et al., “Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 291, no. 5, pp. L1018–L1026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Dong, J. Li, Y. Lv et al., “Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase,” BMC Immunology, vol. 14, no. 1, article 25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Onorati, A. S. Rubino, A. Cuda et al., “Impact of endothelial activation on infective and inflammatory complications after cardiac surgery in type II diabetes mellitus,” The International Journal of Artificial Organs, vol. 34, no. 6, pp. 469–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. S. A. Hoffman, L. Wang, C. V. Shah et al., “Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation,” American Journal of Transplantation, vol. 9, no. 2, pp. 389–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Mathur, M. Baz, E. D. Staples et al., “Cytokine profile after lung transplantation: correlation with allograft injury,” Annals of Thoracic Surgery, vol. 81, no. 5, pp. 1844–1849, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. F. Onorati, F. Santini, G. Mariscalco et al., “Leukocyte filtration ameliorates the inflammatory response in patients with mild to moderate lung dysfunction,” The Annals of Thoracic Surgery, vol. 92, no. 1, pp. 111–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. R. S. Vasan, “Biomarkers of cardiovascular disease: molecular basis and practical considerations,” Circulation, vol. 113, no. 19, pp. 2335–2362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. P. E. Bratcher and A. Gaggar, “Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA,” PLoS ONE, vol. 9, no. 11, Article ID e111466, 2014. View at Publisher · View at Google Scholar